Laura Ungar's article "An impressive decline in breast cancer deaths over the past 20 years" in the daily North American edition of USA Today provides amazing statistical calculations on progress in both early diagnosis and approaches to breast cancer treatment. Mortality decreased from 33:100,000 women per year in 1990 to 22:100,000 women per year in 2011. US experts are convinced that this trend will continue over the next 4 years.
This achievement was the result of a complex of reasons.: more effective treatment, increased awareness, and more women who have had mammograms.
According to Susan Komen, head of wellness and social programs, there is a trend towards more targeted and individualized treatment. This is due to the study of the underlying biological aspects of the tumor. Breast cancer treatment is becoming more and more personalized.
The success in treatment is primarily due to the introduction of new classes of cytostatic drugs, such as targeted therapy, which "paralyzes" cancer cells due to unique mechanisms of action on the molecular level, and hormone therapy, directed against the stimulating estrogenic effect.
Targeted therapy is a fairly gentle type of treatment, since it has virtually no adverse effects on healthy organs, and therefore causes fewer side effects.
GEMS experts fully share the optimism of their North American colleagues. The Institute of Oncology performs oncological screening aimed at detecting not only breast cancer, but also cancerous tumors of any other localization. This complex of diagnostic measures is aimed at detecting malignant tumors in people aged 18-39, 40-49 years and over 50 years. In addition, there is a program to identify hereditary predisposition to breast and ovarian cancer, early diagnosis of prostate cancer, and mammological examination for non-cancerous breast diseases.
We never tire of reminding you that regular screening is the only way to detect cancer at an early stage, which means that it can be effectively controlled. So, according to the Mammography Saves Lives service, out of 1,000 women who performed mammography:
The EMC Institute of Oncology has all the necessary resources and state-of-the-art medical technologies that provide a personalized approach to breast cancer treatment. The use of targeted therapy along with cytostatic chemotherapy is also possible for lung cancer, ovarian cancer, colorectal cancer, kidney cancer, prostate cancer, malignant lymphomas, thyroid cancer, disseminated melanoma, and tumors of the central nervous system.
Using Western methods of cytostatic treatment, the clinic's specialists can ensure minimal toxicity of the treatment, maintain working capacity during antitumor treatment and achieve the same high results in cancer healing rates as in leading Western clinics.
On March 1, 2015, the EMC launched the social campaign "Second Opinion in Oncology", where patients can receive qualified advice based on the achievements of Western medicine.